Science Explorer Back to mapMap
Discussion
Company · Hayward · United States

Anthera Pharmaceuticals (United States)

Research works
41
▼ 44% vs 2018-21
Citations
915
22.4 per fractional work
Top-10% rate
9.0%
all institutions 10.0%
Open access
37%
world 40%
International
30%
world 18%

Not ranked overall: Anthera Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Anthera Pharmaceuticals (United States) work in?

In all years, 68% of research at Anthera Pharmaceuticals (United States) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (17%), Neuroscience (6%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 28 fractional works · 67.6% of its workMedicine: 27 fractional works · 66.2% of its workOphthalmology: 4 fractional works · 10.7% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 7.9% of its workImmunology and Allergy: 2 fractional works · 4.9% of its workSurgery: 2 fractional works · 4.8% of its workPharmacology: 2 fractional works · 3.9% of its workRheumatology: 1 fractional works · 3.6% of its workPhysiology: 1 fractional works · 3.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 3.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.9% of its workOncology: 1 fractional works · 2.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.7% of its workDermatology: 1 fractional works · 2.5% of its workGenetics: 1 fractional works · 2.0% of its workPsychiatry and Mental health: 1 fractional works · 2.0% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.8% of its workEpidemiology: 1 fractional works · 1.5% of its workPathology and Forensic Medicine: 1 fractional works · 1.4% of its workUrology: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.7% of its workNephrology: 0 fractional works · 0.6% of its workHepatology: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.0% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.4% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workLife Sciences: 11 fractional works · 27.1% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 16.6% of its workMolecular Biology: 5 fractional works · 11.8% of its workCancer Research: 1 fractional works · 2.3% of its workClinical Biochemistry: 0 fractional works · 0.9% of its workBiochemistry: 0 fractional works · 0.8% of its workCell Biology: 0 fractional works · 0.8% of its workNeuroscience: 2 fractional works · 5.7% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.6% of its workSensory Systems: 1 fractional works · 1.6% of its workEndocrine and Autonomic Systems: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 3.1% of its workImmunology: 1 fractional works · 3.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.6% of its workPharmaceutical Science: 0 fractional works · 1.2% of its workToxicology: 0 fractional works · 0.4% of its workPhysical Sciences: 1 fractional works · 2.8% of its workEngineering: 1 fractional works · 1.8% of its workBiomedical Engineering: 1 fractional works · 1.4% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 1.0% of its workAnalytical Chemistry: 0 fractional works · 1.0% of its workSocial Sciences: 1 fractional works · 2.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.2% of its workEconomics and Econometrics: 0 fractional works · 1.2% of its workPsychology: 0 fractional works · 1.2% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.8% of its workSocial Psychology: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKAntheraPharmaceuticals…41fractional works, all years
Life Sciences27%Physical Sciences3%Health Sciences68%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine2766.2%
    2. Health Professions01.0%
    3. Nursing00.4%
    1. Biochemistry, Genetics and Molecular Biology716.6%
    2. Neuroscience25.7%
    3. Immunology and Microbiology13.1%
    4. Pharmacology, Toxicology and Pharmaceutics11.6%
    1. Engineering11.8%
    2. Chemistry01.0%
    1. Economics, Econometrics and Finance01.2%
    2. Psychology01.2%
    3. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Anthera Pharmaceuticals (United States)?

Ranked on the quality score, Colin Hislop, Heather I. Fraser and Renée S. Martin lead among researchers whose main affiliation is Anthera Pharmaceuticals (United States).

  1. 1 Colin Hislop United States · #596,681 worldwide 1.3k citations · 32 works
  2. 2 Heather I. Fraser United States · #2,148,127 worldwide 1.6k citations · 42 works
  3. 3 Renée S. Martin United States · #2,364,313 worldwide 1.5k citations · 58 works
  4. 4 James A. Gow United States · #2,546,396 worldwide 737 citations · 41 works
  5. 5 Timothy R. McNamara United States · #5,030,424 worldwide 321 citations · 26 works
  6. 6 Jon I. Williams United States · #5,268,097 worldwide 1.7k citations · 68 works
All ranked researchers at Anthera Pharmaceuticals (United States)

What are the most cited papers from Anthera Pharmaceuticals (United States)?

The most cited paper from Anthera Pharmaceuticals (United States) is "EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS" (Lloyd Paul Aiello, Alexander J. Brucker, Stanley Chang et al., 2004), with 413 citations. Next come "A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study" (170) and "Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial" (161).

Most cited papers
#PaperReleasedCitations
1 EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS Lloyd Paul Aiello, Alexander J. Brucker, Stanley Chang et al. · Retina Oct 2004 413
2 A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study Richard Alan Furie, Gastón P. León, Meenu Thomas et al. · Annals of the Rheumatic Diseases 20 Apr 2014 170
3 Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial Joan T. Merrill, William R Shanahan, Morton Aaron Scheinberg et al. · Annals of the Rheumatic Diseases Open access Jun 2018 161
4 Fomivirsen Richard S. Geary, Scott P. Henry, Lisa R. Grillone · Clinical Pharmacokinetics 2002 159
5 Characterization of pulmonary function in Duchenne Muscular Dystrophy Oscar Henry Mayer, Richard S. Finkel, Christian Rummey et al. · Pediatric Pulmonology Open access 9 Mar 2015 156
All 76 most cited papers, with filters and sorting

Which keywords describe research at Anthera Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Dry Eye Disease, Ocular Surface, Inflammation, Glaucoma, Neurodegeneration and Optical Coherence Tomography.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology7▲ 4.2×10 topics
  2. Inflammation4▲ 3.7×16 topics
  3. Quality of Life3▲ 6.0×5 topics
  4. Dry Eye Disease3▲ 183×1 topic
  5. Ocular Surface3▲ 183×1 topic
  6. Glaucoma2▲ 37×4 topics
  7. Neurodegeneration2▲ 16×2 topics
  8. Optical Coherence Tomography2▲ 45×2 topics
  9. Risk Factors2▲ 4.9×3 topics
  10. Oxidative Stress2▲ 2.7×10 topics
  11. Cancer Therapy2▲ 7.2×8 topics
  12. Clinical Trials2▲ 7.5×5 topics
  13. Retinal Ganglion Cells2▲ 35×2 topics
  14. Allergen-specific Immunotherapy2▲ 112×1 topic
  15. Asthma2▲ 35×1 topic
  16. Intraocular Pressure2▲ 43×2 topics
  17. Ocular Hypertension2▲ 66×1 topic
  18. Optic Nerve2▲ 46×2 topics
  19. Visual Field Progression2▲ 66×1 topic
  20. Cell Signaling1▲ 10×4 topics
  21. Chronic Pain1▲ 15×3 topics
  22. Metabolic Syndrome1▲ 4.1×6 topics
  23. Stem Cells1▲ 12×2 topics
  24. Atherosclerosis1▲ 8.6×6 topics
  25. Autoantibodies1▲ 14×2 topics
  26. Calcium Signaling1▲ 24×3 topics
  27. Cardiovascular Disease1▲ 2.9×8 topics
  28. Cell Migration1▲ 39×2 topics
  29. Genetic Variants1▲ 15×3 topics
  30. Muscle Regeneration1▲ 93×1 topic
  31. Skeletal Muscle Atrophy1▲ 93×1 topic
  32. Angiogenesis1▲ 7.3×4 topics
  33. Intravitreal Injection1▲ 44×2 topics
  34. Obesity1▲ 4.0×9 topics
  35. Transcriptional Regulation1▲ 11×3 topics
  36. Depression1▲ 3.5×2 topics
  37. Toll-like Receptors1▲ 16×2 topics
  38. C-Reactive Protein1▲ 29×2 topics
  39. Contact Allergy1▲ 88×1 topic
  40. Skin Sensitization1▲ 88×1 topic

Which research topics does Anthera Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Muscle Physiology and Disorders, Inflammatory mediators and NSAID effects, Drug Solubulity and Delivery Systems and Pharmaceutical studies and practices.

  1. 1 Muscle Physiology and Disorders Molecular Biology 0 works
  2. 2 Inflammatory mediators and NSAID effects Pharmacology 0 works
  3. 3 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  4. 4 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  5. 5 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works
  6. 6 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  7. 7 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works
  8. 8 GDF15 and Related Biomarkers Rheumatology 0 works
  9. 9 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
  10. 10 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.0%not open63.0%

World: 40% of research is openly available.

with international co-authors30.0%domestic only70.0%

World: 18% is written across borders.

How has Anthera Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 44% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Anthera Pharmaceuticals (United States) as a percentage of every work published that year, 0.000024% in 2022.

0.000050%0.00010%0.00015%Anthera Pharmaceuticals (United States)0.000034% in 20231990200020102020

Fractional works of Anthera Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hayward

All research institutions in Hayward

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Anthera Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.